CYP3A Activity and Rivaroxaban Serum Concentrations in Russian Patients with Deep Vein Thrombosis.
| Author | |
|---|---|
| Abstract | :
Rivaroxaban is metabolized in the liver via CYP3A4, the cytochrome involved in the metabolism of nearly 50% of all medications. Thus, its effective concentration depends on multiple pharmacologic parameters. |
| Year of Publication | :
2018
|
| Journal | :
Genetic testing and molecular biomarkers
|
| Volume | :
22
|
| Issue | :
1
|
| Number of Pages | :
51-54
|
| ISSN Number | :
1945-0265
|
| DOI | :
10.1089/gtmb.2017.0152
|
| Short Title | :
Genet Test Mol Biomarkers
|
| Download citation |